fda ruling on tirzepatide today Is Approved? FDA moves to remove GLP-1

Demand for rapid weight loss drugs is not fading anytime soon, experts say.

*Breaking* Top-line results positive of the highly anticipated #SOUL trial, the first powered CVOT of an oral #GLP1RA 14% reduction in MACE with oral semaglutide among 9,650 people with T2D and established CV disease and/or CKD

As I've learned from previous experience, it's just not possible to go everywhere - especially when you have to wait up to 45 minutes for a bus to come, making a round-trip to an ice cream shop a full afternoon event.

DataM Intelligence has released a new research report titled Diabetes Drugs Market Size 2026 The report delivers in depth insights into key market dynamics including regional growth trends market segmentation CAGR projections and the revenue performance of leading industry players ...

Brain fog can result from various physical and mental health ailments, including autism, chronic inflammation, depression, anxiety, fibromyalgia, substance use, and celiac disease.1, 2 Treatment focuses on addressing the underlying issues contributing to symptoms.